Skip to main content
SpringerLink
Log in

B-Type Natriuretic Peptide in Heart Transplantation: An Important Marker of Allograft Performance

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

The successful management of a cardiac allograft recipient centers around detection of allograft dysfunction early and preferably in a noninvasive manner. Up to this point, echocardiography or right heart catherization with endomyocardial biopsy are the only definitive methods available to diagnose allograft dysfunction. However, these methods do not reflect early structural changes and neurohormonal aberrations involved in allograft dysfunction. B-type natriuretic peptide (BNP) reflects ventricular wall stress and pressure and early studies have intimated potential usefulness of this marker in heart transplantation. Recent studies utilizing point-of-care BNP assay in heart transplant recipients have demonstrated elevated BNP levels at baseline compared with controls. Furthermore, the two most significant correlates of BNP levels are central hemodynamic perturbations despite preserved systolic function and presence of right sided cardiac dysfunction. Initial investigations have demonstrated BNP levels to serve as prognostic marker for cardiac related events and to track responses to therapeutic interventions. Further studies are needed to further assess the utility of BNP as surrogate marker for cardiac function and adaptation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart: Production in the ventricle. Hypertension 1991;17:1152–1156.

    Google Scholar 

  2. Ogawa Y, Nakao K, Mukoyama M, Hosoda K, Shirakami G, Arai H, Saito Y, Suga S, Jougasaki M, Imura H. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circulation Research 1991;69:491–500.

    Google Scholar 

  3. Mukoyama M, Nakao K, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure [Letter]. N Engl J Med 1990;323;757–758.

    Google Scholar 

  4. Yoshimura M, Yasue H, Okamura K, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464–469.

    Google Scholar 

  5. Kohno M, Horio T, Yokokawa K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1991;92:29–34.

    Google Scholar 

  6. Buckley MG, Sethi D, Markandu ND, Sagnella GA, Singer DRJ, MacGregor GA. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clinical Science 1992;83:437–444.

    Google Scholar 

  7. Ationu A, BurchM, SingerD, Littleton P, CarterN. Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovascular Research 1993;27:188–191.

    Google Scholar 

  8. Ationu A, Sorensen K, Whitehead B, Singer D, Burch M, Carter ND. Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children—a three year follow up. Cardiovascular Research 1993;27:2135–2139.

    Google Scholar 

  9. El Gamel A, Yonan NA, Keevil B, Warbuton R, Kakadellis J, Woodcock A, Campbell CS, Rahman AN, Deiraniya AK. Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation. Ann Thorac Surg 1997;63:1095–1100.

    Google Scholar 

  10. Geny B, Follenius M, Epailly E, Charpentier A, Brandenberger G, Eisenmann B, Haberey P, Piquard F. Transient reduction without normalization of brain natriuretic peptide early after heart transplantation. J Thorac Cardiovasc Surg 1998;115:473–475.

    Google Scholar 

  11. Buckley MG, Yacoub MH, Singer DRJ. Investigation of the plasma concentrations and circulating forms of BNP and ANP in orthotopic cardiac transplant recipients. J of Human Hypertension 1998;12:825–826.

    Google Scholar 

  12. Masters RG, Davies RA, Veinot JP, Hendry PJ, Smith SJ, de Bold AJ. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 1999;100:287–291.

    Google Scholar 

  13. Murdoch DR, Byrne J, Morten JJ. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: Implications for clinical practice. Heart 1997;78:594–597.

    Google Scholar 

  14. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161–167.

    Google Scholar 

  15. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Circulation 2002;106:416–422.

    Google Scholar 

  16. Park MH, Scott RL, Uber PA, Harris BC, Chambers R, Mehra MR. Usefulness of b-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol 2002;90:1326–1329.

    Google Scholar 

  17. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of b-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379–385.

    Google Scholar 

  18. Kazanegra R, Cheng V, Gaccia A, Krishnaswamy P, Gasdetto N, Clopton P, Maisel AS. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressure in patients treated for decompensated heart failure: A pilot study. J Card Fail 2001;7:21–29.

    Google Scholar 

  19. Cheung BMY. Plasma concentration of brain natriuretic peptide is related to diastolic function in hypertension. Clin Exp Phamacol and Physiol 1997;24:966–968.

    Google Scholar 

  20. Lubien E, DeMaria A, Krishnaswamy P, Cloptin P, Koon J, Kazanegra R, Gardetto N, Warner E, Maisel AS. Utility of b-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity reading. Circulation 2002;105:595–601.

    Google Scholar 

  21. Bhatia SJ, Kirshenbaum JM, Shemin RJ, et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthopic cardiac transplantation. Circulation 1987;76:819–826.

    Google Scholar 

  22. Chan MCY, Giannetti N, Kornbluth M, Valentine HA, Hunt SA. Severe tricuspid regurgitation after heart transplantation. J Heart Lung Transplant 2001;20:709–717.

    Google Scholar 

  23. Mehra MR, Uber PA, Uber WE, Park MH, Scott RL. Anything but a biopsy: Noninvasive monitoring for cardiac allograft rejection. Current Opinion in Cardiology 2002;17:131–136.

    Google Scholar 

  24. Master RG, Davies RA, Veinot JP, Hendry PJ, Smith SJ, de Bold AJ. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 1999;100:287–291.

    Google Scholar 

  25. Park MH, Scott RL, Uber PA, Mehra MR. Bedside b-type natriuretic peptide and acute non-cellular cardiac allograft rejection. J Heart Lung Transplant 2002;21:613–614.

    Google Scholar 

  26. Uber PA, Mehra MR, Harris B, Scott RL, Park MH. Steroid weaning in heart transplantation is associated with decreased b-type natriuretic peptide: Surrogate evidence of cardiac adaptation. Transplant Proc 2002;34:1843–1844.

    Google Scholar 

  27. Park MH, Uber PA, Nasca PF, Scott RL, Mehra MR. Temporal patterns in b-type natriuretic peptides predict cardiac hospitalizations in heart transplantation. J Heart Lung Transplant 2003;22:S157.

    Google Scholar 

  28. Mehra MR, Uber PA, Park MH, Scott RL. B-Type natriuretic peptide and peak aerobic capacity: Insights into allograft determinants of exercise limitations following heart transplantation. J Heart & Lung Transplant 2002;21(1):90/98.

    Google Scholar 

  29. Park MH, Uber PA, Scott RL, Bourgeois LE, Mehra MR. Renin-angiotensin-aldosterone-system directed antihypertensive therapy achieves lower B-type natriuretic peptide levels compared with calcium channel blockade in heart transplantation. J Heart & Lung Transplant 2002;21(1):120/180.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ochsner Clinic Foundation, Cardiomyopathy and Heart Transplant Center, New Orleans, LA, USA

    Myung H. Park, Patricia A. Uber, Robert L. Scott & Mandeep R. Mehra

Authors
  1. Myung H. Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patricia A. Uber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert L. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mandeep R. Mehra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mandeep R. Mehra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, M.H., Uber, P.A., Scott, R.L. et al. B-Type Natriuretic Peptide in Heart Transplantation: An Important Marker of Allograft Performance. Heart Fail Rev 8, 359–363 (2003). https://doi.org/10.1023/A:1026199400166

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026199400166

Search

Navigation